Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03157258 |
Other study ID # |
PRO28750 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 8, 2017 |
Est. completion date |
June 30, 2022 |
Study information
Verified date |
February 2023 |
Source |
Medical College of Wisconsin |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
People living with HIV infection (PLH) are clustered in friendship groups with other HIV+
persons, and an intervention delivered to all members of PLH social networks allows HIV+
people who are friends in day-to-day life to provide one another with support for entering,
remaining, and adhering to HIV medical care. Moreover, an intervention delivered to groups
attended by HIV+ persons who are friends increases HIV medical care engagement and decreases
problem drinking more than individual counseling, probably because the network intervention
harnessed mutual peer social support among friends who share the same HIV status, face
similar coping issues, and interact together in day-to-day life. The planned research will be
conducted in two phases in St. Petersburg, Russia.
Description:
Phase I of the planned research will be the conduct of in-depth interviews with 30 HIV+
persons not in medical care or not adherent to anti-retroviral therapy (ART) regimens,
including men and women representing diverse exposure risks (drug use, men who have sex with
men, and heterosexual transmission). Interviews will elicit information on ways in which
HIV-positive friends can support one another in HIV care entry, retention, and adherence;
types of support from PLH friends that would best support treatment engagement; and how peer
supports can lessen the negative effects of substance use on care engagement.
Phase 2 will recruit 48 out-of-care or ART nonadherent HIV+ individuals from community
settings in St. Petersburg, Russia. These individuals, who are referred to as "network
seeds," will invite their HIV+ friends, who will in turn invite their own HIV+ friends into
the study, creating a sample of 48 networks (expected n=288, 6 members/network x 48
networks). Following baseline assessment of care engagement, ART adherence, treatment
attitudes, psychosocial distress, substance use, and CD4+ and viral load, 24 networks (n=144
participants) will be randomized to an intervention condition and 24 networks (n=144) to the
comparison condition. All members of each intervention condition network will together attend
a 4-session intervention to strengthen attitudes, intentions, and skills for entering,
remaining, and adhering to HIV medical care. Because participants will attend sessions with
other individuals who are their own friends in day-to-day life, the intervention will build
and increase mutual social support within each network for HIV care and adherence. Peer
champions identified in each intervention network will attend 3 additional sessions in which
they are guided to reinforce and help to sustain friends' medical care engagement.
Intervention outcomes will be determined by baseline to 6- and 12-month followup change on
primary measures of participant attendance at HIV medical care visits, adherence to ART
regimens, and viral load as well as secondary measures of alcohol use, drug use, sexual risk
behavior, treatment attitudes, and psychosocial distress.